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Abstract
The emergence of distinct neuropathogenic strains resulting from the adaptation and the unique
evolution of human immunodeficiency virus (HIV) in the brain may contribute to the development
of HIV-induced neurological diseases. In this study, the authors tracked early changes in virus
evolution and compartmentalization between peripheral tissues and the central nervous system
(CNS) after intracerebroventricular (i.c.v.) or intraperitoneal (i.p.) inoculation of animals with cell-
free feline immunodeficiency virus (FIV). Using the FIV-NCSU1 envelope V3–V4 heteroduplex
tracking assay (HTA), the authors observed a rapid compartmentalization of envelope variants
between the CNS and periphery. Animals receiving the i.c.v. inoculation showed two peaks of
viral RNA in the cerebrospinal fluid (CSF) with very different HTA patterns. Compared to the
initial viral peak in CSF, the second peak showed an increased compartmentalization from plasma,
reduced viral diversity, and more divergence from the proviral DNA in peripheral blood
mononuclear cells (PBMCs) and the choroid plexus. In contrast, changes in plasma over the same
time period were small. Different animals harbored different FIV DNA genotypes with varied
regional compartmentalization within the brain. These results demonstrated that the virus within
the CNS experienced a relatively independent but variable evolution from the periphery. Initial
penetration of virus into the CSF facilitated the development of brain-specific reservoirs and viral
diversification within the CNS.
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HIV-1 rapidly penetrates into the brain of most infected individuals and gives rise to a wide
range of cognitive-motor symptoms ranging from undetectable to severe dementia (Davis et
al, 1992; Bell et al, 1993; Gonzalez-Scarano and Martin-Garcia 2005; van Marle and Power
2005). The early penetration of virus into the central nervous system (CNS) rarely gives rise
to significant neurological disease, yet is thought to set the stage for a slow, progressive
deterioration of neuronal function (Gonzalez-Scarano and Martin-Garcia 2005; van Marle
and Power 2005), due, in part, to the development of an inflammatory response and
ultimately, the failure to control virus replication in the CNS. It has been suggested that this
variability in neuropathogenesis could, in part, be due to the emergence of unique
neurovirulent quasispecies in some individuals (Zink et al, 1997; Power et al, 2004; van
Marle and Power 2005). Patients with human immunodeficiency virus (HIV)-1–related
neurological diseases have increased viral diversity within the choroid plexus and brain
(Hughes et al, 1997; van Marle and Power 2005). Viral isolates from these patients are more
likely to cause neuronal apoptosis and trigger the secretion of inflammatory substances by
monocytic cells compared to isolates from HIV-infected individuals without neurological
diseases (Zink et al, 1997; Gorry et al, 2002; Power et al, 2004). In addition, the HIV-1
envelope (env) protein, gp120, from a neurovirulent primary HIV-1 strain required lower
levels of expression of CD4 and CCR5 to enter and infect target cells than the env protein
from non-neurovirulent stains with similar neurotropism (Gorry et al, 2002). All these
findings suggest that distinct neuropathogenic strains may result from the adaptation of the
virus to the unique environment of the brain. However, little is known about the forces that
shape the evolution of the virus in the CNS. Most studies done postmortem have indicated
that HIV-1 evolves in the CNS independently from HIV-1 in peripheral organs. Genetic
studies comparing HIV-1 from the CNS with that in blood or peripheral organs have
identified sequence differences in env, pol, gag, nef, tat, and long terminal repeats (LTRs)
(Blumberg et al, 1992; Ait-Khaled et al, 1995; Wong et al, 1997; Chang et al, 1998; Smit et
al, 2004; van Marle and Power, 2005). The origin of these sequence differences is not clear
but could be due to either constraints on trafficking or unique interactions of the virus with
cells in the CNS. One potential site for viral interactions that might support diversification is
via the trafficking of virus through the choroid plexus into the cerebrospinal fluid (CSF).
The choroid plexus has been demonstrated to be a prominent site for lentiviral infection
(Falangola et al, 1995; Bragg et al, 2002a; Burkala et al, 2005) and contains a mixture of
viral quasispecies with sequences similar to those in both systemic organs and brain tissue
(Chen et al, 2000; Burkala et al, 2005). Macrophages and dendritic cells that reside in the
choroid plexus stroma (Falangola et al, 1995; Bragg et al, 2002b) are primary targets for
infection but the level of productive infection of theses cells is typically low (Bragg et al,
2002a). However, these cells can efficiently transfer infection to T cells (Bragg et al,
2002a), raising the possibility that they may serve as effective vehicles for the transfer of
infectious virus to other cells. Once the virus/infected macrophages penetrate into the CSF,
they have access to ventricular macrophages and periventricular brain structures in an
environment in which antiretroviral compounds are absent or suboptimal. These conditions
may favor the development of brain-specific reservoirs and the evolution of resistant strains
(Schrager and D’Souza, 1998).
In addition, the CSF pathway may serve as an effective means by which viruses exit the
CNS, thereby providing a continuous flow of virus from the protected brain environment
(Liu et al, 2006). In a previous study of cats infected with feline immunodeficiency virus
(FIV), we found that direct inoculation of virus into the lateral ventricle gave rise to
unusually high CSF viral RNA titers, a higher proviral burden in the brain, and the
development of a secondary CSF peak of viral RNA at 9 to 32 weeks post inoculation (Liu
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et al, 2006). In the present study, longitudinal samples from these cats were used to evaluate
FIV env V3–V4 sequence variation and compartmentalization between the CNS and
periphery following intracerebroventricular (i.c.v.) or intraperitoneal (i.p.) inoculation. A
high degree of compartmentalization between the CNS and periphery was observed soon
after infection. Greater variation between the systemic tissues and the brain was seen after
i.c.v. inoculation, indicating that early penetration of virus into the CSF facilitated the
development of brain-specific reservoirs and viral diversification.
Results
Plasma FIV diversity over time following systemic or i.c.v. inoculation
All nine cats inoculated with cell-free FIV (six i.c.v., three i.p.) developed a significant
infection and inversion of in the CD4+:CD8+ T-cell ratio. A detailed analysis of the kinetics
of the plasma and CSF virus has been reported (Liu et al, 2006). The duration of the
experiments ranged from 12 to 56 weeks and was based on the time required for the CSF
viral loads to return to undetectable levels (32 to 56 weeks post inoculation, eight cats) or for
the appearance of significant neurological disease (12 weeks post inoculation, cat 5). Time
points were selected for heteroduplex tracking assay (HTA) analysis that represented the
initial CSF viral peak (paired blood and CSF, all nine cats), the second CSF peak (paired
blood and CSF, five of six cats inoculated i.c.v.), and paired blood and tissue samples
collected at euthanasia. The diversification of virus was determined by comparison of
samples to the original inoculum (diversification from the stock virus) as well as to the
patterns seen in the first viral peak (diversification over time). A summary of FIV RNA
copy numbers determined at each of the time points is provided in Table 1. Negative
controls for the HTA included S35-labeled probe alone with and without the denaturing step,
the mix of labeled probe with internal primers (Fenv2 and Fenv3), the polymerase chain
reaction (PCR) product from the probe plasmid and samples from FIV-negative cats. The
results from these controls, illustrated in Figure 1A, showed the homoduplex and/or single
stranded probe but no heteroduplexes. The HTA profile for the virus inoculum was also run
for comparison (Figure 1B) with samples obtained from the FIV-infected cats. All samples
were run in duplicate for confirmation of the variant patterns. Examples of changes in the
plasma FIV HTA patterns over time are contrasted with the inoculum profile in Figure 1B.
Because all heteroduplex variants were clustered in the lower (bottom) portion of the gel,
only the lower portion is shown. Based on their relative mobility, across all samples, seven
distinct bands were identified and designated variant (V) V1 to V7 with V1 representing the
band with the highest mobility, the homoduplex. Four diffuse bands were identified in the
inoculum which corresponded to V1, V2, V4, and V6 with a relative abundance of 34.0%,
32.4%, 23.3%, and 10.4%, respectively. To assess virus diversification over time in plasma,
the HTA patterns were compared at three different times corresponding to the acute peak
viremia (2 to 4 weeks), the period in which the second CSF peak developed (9 to 24 weeks
post inoculation) and the euthanasia time point (32 to 56 weeks post inoculation). The HTA
patterns of two typical cats are shown in Figure 1B and C. Figure 1B shows the bands in the
gel and Figure 1C shows the optical density (OD) scan of the lower gel with peaks matched
according to relative mobility. Dashed lines indicate the position of major bands
corresponding to V1 to V7. These examples illustrate two important features of virus
diversification in plasma. First, there was no significant viral env divergence between the
initial viremia (at 2 to 4 weeks post inoculation) and the intermediate viremia (at 9 to 24
weeks post inoculation) in most cats (7/9). A small increase in viral diversification from the
initial viremia was seen at 32 to 56 weeks post inoculation due largely to the enrichment of
specific variants. Second, the patterns that developed varied considerably between cats. For
example, in cat 6 a large intermediate band is enriched over time, whereas in cat 4 different
variants become enriched over time.
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The average variability in the plasma HTA pattern relative to the inoculum for each cat at
each time point is illustrated in Figure 2. The mean difference in the plasma HTA profile at
each time point relative to the inoculum was 19.0% ± 3.6% at 2 to 4 weeks, 17.4% ± 2.6% at
9 to 24 weeks post inoculation, and 28.4% ± 4.0% at euthanasia (32 to 56 weeks post
inoculation), reflecting a gradual increase in diversity after 24 weeks post inoculation. When
compared to the initial plasma viremia peak at 2 to 4 weeks post inoculation, a significant
change in virus diversity was first seen at 32 to 56 weeks post inoculation (t = 4.804, P = .
002). Variation in the plasma HTA pattern did not correlate with the peak viral load (r2 = .
012) and occurred well after both the drop in the CD4+:CD8+ T-cell ratio and the
appearance of the second CSF viral peak (Liu et al, 2006). A comparison of the temporal
variation in HTA between the i.p. and the i.c.v. cats indicated that the cats infected
intraperitoneally showed significantly greater divergence in plasma at euthanasia than did
the i.c.v. cats (38.95% ± 5.06%for i.p. cats versus 22.15% ± 3.17% for i.c.v cats; t = 2.992,
P = .03). No significant differences between the i.p. cats and the i.c.v. cats were seen in the
plasma at the 2–4 and 9–24-week time points.
Compartmentalization of FIV RNA in CSF versus plasma
Paired blood plasma and CSF samples at the first CSF viral peak and the second CSF viral
peak were selected to analyze virus complexity in the CSF over time as well as the
compartmentalization of FIV in CSF relative to plasma. Comparisons between the i.c.v.
versus i.p. inoculated cats for the initial viral peaks in CSF were also done to indicate if
introduction of virus into the ventricles resulted in an unique pattern of viral genotypes. A
comparison of the HTA profiles found in the initial CSF peak with the matched plasma
sample revealed only a modest difference of 25.15% ± 6.3% for the i.c.v. cats and 20.01 ±
9.48% for the i.p. cats. Because it is difficult to know how much of a difference represents
“significant” viral diversification from normal variation, we attempted to establish
reasonable guidelines. We conservatively assumed that the diversity seen across cats at the
initial plasma viremia reflects natural sampling variation. The average diversity at the initial
infection was 19.1% ± 3.6% with an upper 95% confidence interval of 26.1%. Values under
this were considered to reflect random variation. Thus, based on this analysis, the slight
variation in the first CSF peak relative to plasma was considered to be within the normal
range.
Variation in the CSF over time was evaluated by contrasting the HTA patterns of the first
peak with the second peak. Examples of the temporal changes in the HTA patterns for CSF
and matched plasma samples are illustrated in Figures 3 and 4. In most cats (seven of nine),
changes in the CSF HTA profile was due to enrichment of particular bands also present in
plasma (Figure 3). However, the pattern that appeared in the CSF was highly variable
between individual cats with no single band preferentially expressed. In two cats, a
relatively unique band appeared in the CSF that was not present in the matched plasma
samples. The plasma and CSF profiles for one of these cats illustrated in Figure 4 (cat 5),
shows a band (V7) in the CSF at 2 and 9 weeks post inoculation that was absent in plasma.
However, because of a possible presence of a very weak signal for V7 at 2 weeks post
inoculation, we cannot discount the possibility that it might have been present as a minor
early variant in the plasma. In this cat, V5 was also enriched in the second CSF peak relative
to the first CSF peak. This was the only cat (cat 5, Figure 4) that developed significant
neurological disease over the course of these experiments.
The appearance of a second peak of FIV RNA in the CSF of five of the six i.c.v. cats
allowed the calculation of mean CSF FIV env variation over time. When compared to the
matched plasma sample, the first CSF peak showed an average diversity of 23.4% ± 5.0%.
The second CSF peak showed a substantial increase in diversity from the matched plasma
samples (47.4% ± 12.0%; P = .05). Because the plasma HTA profile did not change within
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this time frame (9 to 32 weeks, e.g., Figure 2), it is unlikely that it would have contributed to
the increased diversity in the CSF. Examples of the types of changes seen in CSF are
illustrated by the optical density (OD) profiles in Figure 5. The HTA profile for the first and
second CSF viral peaks is shown in the upper portion of each figure. Dashed lines show the
position of major peaks in the CSF. The FIV env divergence in the CSF over time was due
to the enrichment of specific variants (Figure 5, cats 2, 3, and 4) as well as the appearance of
variants unique to the CSF (Figure 5, cat 5). The expression patterns tended to simplify over
time with a decrease in the average number of variants in the CSF from 3.60 ± 0.24 to 2.60 ±
0.51. However, as seen in Figure 5, the specific bands that were enriched in the CSF varied
substantially between cats indicating that there was no consistent selection for particular
variants in the CSF compartment.
HTA analysis of FIV DNA in brain
Although no productive FIV infection was seen by real time reverse transcriptase (RT)-PCR
in brain at euthanasia, a significant FIV DNA burden was seen in the i.c.v. cats. Comparison
of the brain FIV DNA HTA patterns to CSF, plasma, peripheral blood mononuclear cells
(PBMCs), and lymph nodes revealed a unique compartmentalization within the brain. The
bottom panel for each of the four cats illustrated in Figure 5 shows the HTA OD profiles for
the FIV env V3–V4 fragment amplified from genomic DNA extracted from four brain
regions (frontal cortex gray matter, underlying cortical white matter, caudate nucleus,
internal capsule/putamen) versus the CSF FIV RNA profiles (Figure 5, upper panel). Again,
dashed lines show the position of major variants in the CSF. In the majority of cases, a band
seen for FIV DNA in the brain had a corresponding peak for FIV RNA in the CSF.
However, with the exception of cat 4, one major band appeared in each brain which was not
prominent in the CSF. No two brain regions gave identical patterns nor did the patterns
preferentially match to the first or the second CSF viral peak. This is well illustrated in the
patterns for cat 3 (Figure 5) where the cortex (CTX), the caudate, and the internal capsule/
putamen (IC-Put) all showed different patterns. Major peaks for the cortex and internal
capsule/ putamen corresponded to peaks seen in the first CSF viral peak, whereas the
caudate matched closely to the second CSF viral peak.
Because periventricular structures were more likely to have been infected via the CSF, we
compared HTA patterns between the brain regions in proximity to the ventricles. A
significant but modest correlation (r2 = .2052, P = .0392) was seen in the relative abundance
of common variants between the choroid plexus and the first CSF peak (Figure 6A, CSF-1)
but not the second CSF peak (CSF-2). A stronger correlation was seen between the
periventricular caudate tissue and the subcortical white matter (r2 = .9627, P < .0001) and
choroid plexus (r2 = .4018, P = .0149; Figure 6B). Thus, although the overall patterns of
brain FIV variants indicate substantial regional diversity, the correlation between HTA
patterns of periventricular structures suggested that they may share a common origin. The
choroid plexus is a strong candidate for the “common” source of FIV variants and is
supported by the modest correlations between choroid plexus and both the first CSF peak
and the caudate. However, considerable diversity was seen between the second CSF peak
and the choroid plexus (40.2% ± 10.5%; t = 3.82, P < .05) and the brain (55.84% ± 6.06%; t
= 5.50, P < .001), reinforcing the idea that the brain and CSF show independent variation.
The contribution of infected PBMCs to brain, CSF, and plasma FIV compartments
In a previous study of the viral kinetics within the same cats, we observed a strong
correlation between the proviral burden in PBMCs and the proviral burden in the brain (Liu
et al, 2006). This suggested that sequences isolated from brain largely reflected the
penetration of cells from the systemic circulation. If this assumption was correct, we would
expect the HTA patterns in the brain to closely match the patterns seen in PBMCs. To begin
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to address the extent to which infected PBMCs might contribute to FIV in various
compartments, we compared HTA patterns of DNA extracted from PBMCs to the patterns
seen in temporally matched samples of the brain, CSF, plasma, and lymph nodes (Figures 7
and 8). Analysis of the HTA profiles for DNA isolated from PBMCs revealed a surprising
homogeneity across all cats with an average variation of 15.7% ± 2.4%. However, as
illustrated in Figure 7, a comparison of the HTA patterns of the PBMCs to those of matched
cortex and basal ganglia revealed considerable variation of 39.4% ± 7.5% (t = 3.18, P = .
0072) and 49.4% ± 11.4% (t = 3.33, P = .0060), respectively. The choroid plexus showed
only modest variation (20.3% ± 6.1%, not significant) from PBMCs. However, although
relative expression patterns differed greatly, most brain variants were also detected in the
matched PBMCs for the majority of the i.c.v. cats (5/6). Cat 2 was the only exception where
V3, a major proviral variant in the caudate, was not seen in the PBMCs. An example of the
different HTA patterns seen across various tissues sampled from cat 5 is illustrated in Figure
8. A similar HTA pattern was seen in the PBMCs, lymph node, and the choroid plexus, in
which five variants were identified (V1, V2, V4, V5, and V7). The percent difference
between PBMCs and lymph node was 10.0% and the percent difference between PBMCs
and choroid plexus was 10.60%, indicating relative homogeneity. In contrast, each brain
region showed a distinct pattern with different variants concentrated in each region.
When PBMC HTA was compared to matched plasma samples across all cats, an average
percent difference of 24.2% ± 3.8% was calculated for the initial viremia at 2 to 4 weeks
post inoculation and remained at a similar level of 25.9% ± 4.6% until euthanasia. The
diversity between PBMCs and plasma at euthanasia was greater for the i.p. cats (38.22% ±
4.24%) than for the i.c.v. cats (19.70% ± 4.98%). A similar difference in diversity between
the i.c.v. cats and the i.p. cats was seen when PBMCs were compared to the superficial
cervical lymph nodes where the i.p. cats showed a difference of 27.07 ± 5.13% versus
11.44% ± 2.14% in the i.c.v. cats. Comparison of PBMCs HTA profiles to changes in CSF
over time showed that PBMCs were relatively stable over time and the pattern of FIV DNA
in PBMCs paralleled the profiles seen for FIV RNA isolated from the first CSF peak
(26.21% ± 5.58% difference) much more closely than for the second peak (45.87% ± 6.85%
difference; t = 5.51, P = .0053). Thus, the relative homologies between the HTA sequences
for PBMCs and the HTA for plasma, lymph nodes, and the first CSF peak are consistent
with PBMCs being a significant source of virus in these compartments whereas the
substantial differences between PBMCs and the brain and second CSF peak suggest an
independent source of virus.
Neurological consequences of i.c.v. inoculation and HTA patterns
Only one cat (cat 5) showed overt neurological symptoms resulting from the i.c.v. infusion
of FIV. Symptoms developed approximately 12 weeks after inoculation and included
profound depression with an absence of postural responses in all limbs. Patellar reflexes
were mildly exaggerated and withdrawal reflexes in all limbs were normal. On cranial nerve
testing, the pupillary light reflex was slow bilaterally and there was a positional nystagmus
present. This nystagmus was oriented vertically with the fast phase in a ventral direction.
The cat had normal facial symmetry with normal palpebral reflexes. Jaw tone and tongue
movements appeared to be normal. The appearance of the neurological symptoms coincided
with a large second peak of increased viral load in the CSF (5.1 × 105 copies/ml, three-fold
higher than the initial peak in CSF), an inversion of the CSF:plasma ratio, and an HTA
profile with a relatively unique CSF variant (V7, Figure 4). This cat also showed the highest
average brain proviral burden with 270 copies/µg DNA versus 46 copies/µg DNA for all
other i.c.v. cats. All other cats, including those infected intraperitoneally, were
asymptomatic for neurological or systemic disease. The inital analysis of brain tissue in cat 5
has shown very little gross pathology, no clear damage in cresyl violet stained sections and a
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few small clusters of Mac387-positive macrophages. It is currently unclear if the
neurological symptoms correlate with observable pathological changes. More detailed
neuropathological studies are underway to define subtle changes that might be associated
with this and other cats receiving i.c.v. inoculation of FIV.
Discussion
High rates of mutation and replication of HIV and other lentiviruses allow for the
continuous generation of genetically heterogeneous quasispecies in vivo (Delwart et al,
1993; Power et al, 2004; van Marle and Power 2005). This facilitates the development of
variants with different cell tropism, allows escape from immune inactivation, increases the
level of virulence, and leads to antiretroviral drug resistance (Gorry et al, 2002; Power et al,
2004; van Marle and Power 2005). Selective pressures that allow the emergence of different
viral quasispecies and strains vary between tissue compartments but are still poorly
understood. This is particularly true in the unique environment of the brain that may harbor
a persistent viral reservoir partially protected from typical immune surveillance and
antiretroviral drugs (van Marle and Power 2005). A growing body of evidence from studies
of CNS infection, HIV evolution, and CSF virology indicate that the trafficking of virus
through the choroid plexus into the CSF may contribute significantly to viral evolution and
CNS infection (Petito et al, 1999; Chen et al, 2000; Bragg et al, 2002a; Burkala et al, 2005).
In the present study, the FIV model was used to track viral env evolution during the early
stages of infection. FIV shares many common characteristics with HIV-1 in molecular
structure and pathogenesis (English et al, 1994; Boche et al, 1996; Willett et al, 1997;
Power et al, 2004). FIV infects primarily T lymphocytes, macrophages, and CNS glial cells,
similar to the cell tropism exhibited by HIV-1 and simian immunodeficiency virus (SIV)
(Dow et al, 1992; English et al, 1993). Like HIV, FIV is a natural infection of domestic cats
resulting in immune deficiency in all infected cats and CNS diseases in a subset of infected
cats (English et al, 1994; Phillips et al, 1994; Power et al, 1998). This animal model affords
the opportunity to study the evolution of FIV in parallel with changes in immune function
and pathogenesis.
Our studies of systemic and CSF viral kinetics following direct inoculation of FIV into the
CSF showed an increased incorporation of FIV DNA in the brain and a unique pattern of
FIV expression in the CSF (Liu et al, 2006). Samples from these cats were used in the
present study to examine the evolution of env variants during the early stages of infection.
We found that inoculation of FIV into the CSF gave rise to a distinct compartmentalization
of variants between the CNS and the periphery. In addition, significant variation was seen
over time in both plasma and CSF, including the appearance of three variants (V3, V5, V7)
identified in the viral RNA and tissue proviral DNA that were not present in the inoculum.
The above observations indicated that FIV env sequences changed rapidly after infection.
These changes are consistent with other observations indicating that the V3–V5 region
contributes to FIV neurotropism and neurovirulence (Johnston and Power, 2002). We
focused on env V3–V4 because this region has a high degree of variability, possesses
determinants involved in macrophage tropism, and affects the release of neurotoxic
molecules (including the envelope protein gp120 itself) following infection of macrophages
(Power et al, 1994, 2004; Nelson et al, 1997). These properties have made this region a
target of many studies of HIV-1 evolution (Epstein et al, 1991; Scarlatti et al, 1997; Chen et
al, 2000; Strain et al, 2005). However, it is important to note that env variation may be only
one of many determinants of viral compartmentalization in the CNS. Indeed, studies have
indicated that long terminal repeat (LTR), gag, and nef sequences also show variation that is
relatively unique to the CNS and this sequence variation may contribute to neurotropism,
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neurovirulence, and resistance to antiretroviral drugs (Corboy and Garl, 1997; Torres-
Munoz et al, 2001; Hogan et al, 2003; Burdo et al, 2004; Smit et al, 2004; van Marle et al,
2004). It is possible that in the relative absence of neutralizing antibody, these factors might
play a greater role than env in CNS infection and virus diversification. Morris et al (1999)
has suggested that a mosaic of variants may ultimately be a better predictor of neurotropism
than any single variant. Thus, whereas sequence variation can be a good index of tissue
specific variation, it must be interpreted cautiously and ultimately validated in vitro and in
vivo.
FIV env variation in the CSF
Similarities between the initial HTA profiles in plasma, PBMCs, choroid plexus, lymph
nodes, and CSF suggested a common source of infection. Viral variants within the choroid
plexus matched sequences from PBMCs and plasma better than brain, suggesting that its
virus load predominantly reflects infiltrating cells. This is consistent with the commonly
observed infection of the choroid plexus. Studies of HIV env V3 sequence variation in
postmortem tissue have shown that the choroid plexus contained an admixture of sequences
typical of sequences in both brain and spleen (Chen et al, 2000; Burkala et al, 2005). This
raises the possibility that the unique environment of the choroid plexus could facilitate the
development of neurotropic quasispecies. The most likely source for the early appearance of
viral RNA in the CSF is trafficking immune cells. Macrophage and cellular barriers between
the vasculature and the choroid plexus epithelium would most likely restrict passage of cell-
free virus from the blood into the CSF. T cells and monocytes trafficking into the choroid
plexus stroma would find themselves in an environment heavily populated by resident
macrophages. Cellular and infectious interactions within the stroma may facilitate adaptation
of the virus to the CNS environment (Falangola et al, 1995) through the expression of mixed
virus populations (Chen et al, 2000). Strong similarities between the HTA patterns in the
CSF FIV RNA and the choroid plexus FIV DNA support this general view for the initial
stages of infection. However, the HTA profiles of the second CSF peak contrasted
dramatically with the first CSF viral peak and the choroid plexus, suggesting that this
delayed virus production had an independent origin. The large variation seen in the CSF at
the second viral peak was particularly noteworthy because it developed before any
detectable variation in plasma FIV. The uniqueness of the second CSF HTA profile was also
reinforced by the lack of correlation with plasma FIV RNA as well as DNA from PBMCs
and systemic tissues. Thus, the intraventricular inoculation with FIV appears to set the stage
for a rapid diversification of FIV env within the CNS. Specific variants enriched in the CSF
differed from cat to cat, indicating that the selective pressure within the brain was not highly
focused to a particular sequence. It should be noted, however, that the variation seen in the
second CSF viral peak was largely due to reduced viral HTA complexity rather than the
appearance of new variants. The enrichment of CSF variants that are also detected in plasma
is similar to studies of HIV-1 in human CSF where selective enrichment was found to be
more common than the generation of new quasispecies (Ritola et al, 2005; Harrington et al,
2005).
The most consistent interpretation of the viral diversity seen in the second CSF peak is the
transient local synthesis of new virus occurring soon after the drop in the CD4+:CD8+ T-cell
ratio. The trigger for this delayed virus production is not known. This interpretation is
supported by studies of Ryan et al (2003), which showed that initial infection of cats with
FIV was followed by a transient productive infection of the brain with a time course similar
to the appearance of our second CSF peak. In their studies, virus was cleared from the CNS
by 30 weeks. This is approximately the same time that we observed the loss of detectable
virus in the CSF. Together, these observations suggest that viral evolution in the brain is
relatively rapid and independent of circulating virus.
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FIV env variation in brain
The widespread incorporation of FIV DNA into brain in the i.c.v. cats allowed a comparison
of regional differences. Considerable variation in the FIV DNA HTA patterns was seen
between brain regions in the same cats as well as between cats. As with the CSF, different
brain regions often displayed a selective enrichment of one or two variants. However, no
consistent relationship was seen between the CSF FIV variants and the regional FIV DNA
sequences in brain. In some cases a strong relationship was found between the HTA pattern
of CSF RNA and the HTA pattern in a particular brain region. This was most often the case
for the caudate nucleus but, again, the particular variant that was enriched varied between
cats. The variable env genotypes of the FIV proviral quasipecies in separate brain regions
within the same cat was consistent with previous findings for HIV-1 in which
subpopulations independently evolved in different brain regions (Chang et al, 1998;
Shapshak et al, 1999). A caveat of these studies that must be kept in mind lies in the fact that
no productive infection was seen in the brain at the time of euthanasia. Because the intention
of the study was to follow the fate of the CSF virus until viral loads became negligible, it is
likely that a transient local virus production in the parenchyma was missed. Consequently,
we can only infer what quasispecies might come from the brain based on the available
sequences in the DNA. The lack of a clear relationship between brain and CSF HTA
patterns on the one hand suggests that the brain contributes little to CSF virus. The
appearance of variants in the CSF that were not seen in FIV DNA sequences in brain tissue
support the contribution virus from non-CNS sources. However, no systemic source could
easily account for the diversification seen in the CSF over time. It is possible that the CSF
profiles reflect the selective synthesis of certain variants from the brain. In this case the
brain DNA HTA pattern would not reflect actual viral RNA coming from the brain
compartment. Variants prominent in the caudate were often found to be prominent in the
second CSF sample, providing some indirect support for this view. Overall, the mixed
pattern of variants is consistent with the view that the CSF contains sequences of both
systemic and brain origin.
The weak relationship between proviral HTAs of PBMCs and brain indicated that
trafficking cells did not contribute directly to the brain profile. However, in most cases,
variants in the brain were also present in PBMCs, with differences due to the relative
abundance of individual variants. Thus, PBMCs appear to make little direct contribution to
the diversity seen in brain, although we cannot rule out the possibility that selective
trafficking of different cell subsets (with unique HTA profiles) might contribute to the
differential patterns. Although no clear relationship was seen between the variant patterns in
brain versus other compartments, several observations suggested that virus trafficking
through the CSF may have contributed to viral evolution in specific brain regions. When we
compared HTA patterns in periventricular structures that should be particularly vulnerable to
infection via the CSF inoculation (caudate at the lateral border of the ventricle, cortical
white matter along the dorsal border of the ventricle, and the choroid plexus within the
ventricle), we found similar patterns of expressed variants. Variant patterns from other brain
tissue samples more remote from the ventricles (internal capsule/putamen and cortical gray
matter) did not correlate. A significant, albeit lower, correlation was also seen between the
variants expressed in the caudate versus those seen in the choroid plexus. Thus, a specific
correlation between periventricular regions suggested a common origin and evolution of the
FIV.
Only one variant (V7) emerged that appeared to be somewhat unique to the CNS. Other
studies have demonstrated unique quasispecies of HIV in the CSF relative to plasma (Ritola
et al, 2005). Variant V7 was seen in two cats, one of which developed neurological
symptoms. Although it is tempting to speculate that this virus may represent a more
neurovirulent species, its role in pathogenesis remains to be determined. The absence of this
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variant in the brain tissue DNA, choroid plexus, or PBMCs makes the origin uncertain. In
addition, the absence of overt pathology in the brains of these cats indicates that the
significance of this variant needs to be interpreted cautiously until more detailed
pathological studies are done and further data are collected to support the neurovirulence.
In summary, infection of the brain and viral diversification was greatly enhanced in the cats
receiving the i.c.v. inoculation, providing support for the hypothesis that initial virus
trafficking thorough the CSF plays an early and important role in infection and
diversification. A distinct compartmentalization of variants was seen within the CSF and
brain, although the patterns were highly variable across brain regions and between cats. The
extent of FIV env diversity in CSF and brain relative to other tissues indicates that the CNS
is an important site for viral diversification but the underlying mechanisms are still poorly
understood. A better understanding of this process is needed to develop effective therapeutic
interventions that control early deleterious HIV interactions with the CNS.
Materials and methods
Animals, virus challenge, and collection of samples
The specific pathogen-free (SPF) cats used in the study were screened for FIV and other
common feline infections as previously described (Liu et al, 2006). Briefly, six adult cats at
10 to 18 months of age were intracerebroventricularly inoculated with a total of 200 µl (2 ×
105 TCID50) cell-free NCSU1 FIV into the right lateral ventricle using a sterotaxic apparatus
(Liu et al, 2006). To provide a comparison to systemic infection, three additional cats were
inoculated intraperitoneally with an identical amount of cell-free FIV (2 × 105 TCID50/200
µl). Blood and CSF samples were collected prior to infection and at 1, 2, 4, 6, 9, 12, 16, 20,
24, and 32 weeks post inoculation. Some cats included samples at 40, 48, and 56 weeks post
inoculation as well. The development of significant neurological disease or the complete
clearance of viral RNA from the CSF was used as the endpoints for the studies. Only one cat
(cat 5) manifested neurological symptoms at 12 weeks after infusion of cell-free virus. All
animal procedures were performed in accordance with National Institutes of Health
guidelines and were reviewed and approved by the North Carolina State University College
of Veterinary Medicine Institutional Animal Care and Use Committee.
Preparation of virus inoculums
The NCSU1 strain of FIV, originally isolated from a naturally infected cat with lymphopenia
and acute enteritis, has dual T-cell and macrophage tropism (English et al, 1993; Bragg et
al, 2002a). Cell-free virus inoculum was prepared as described previously (English et al,
1993). Briefly, pooled PBMCs from NCSU1 infected cats were cocultured with a feline
interleukin (IL)-2–dependent CD4+T-cell line (FCD4E cells). Cell supernatant containing
high RT activity was collected, filtered (0.2 µm), and frozen as a source of virus stock. Virus
titer was determined by the 50% tissue culture infectious dose (TCID50) method as
described by Davidson et al (1993).
Viral RNA and DNA extraction
Viral RNA was extracted from 400 µl of CSF or plasma using QIAamp Viral RNA Mini Kit
(Qiagen, CA) according to the manufacturer’s protocol. Genomic total DNA was isolated
from a 30 mg sample from four brain regions (frontal cortex gray matter, underlying cortical
white matter, caudate nucleus, and internal capsule/putamen), the choroid plexus, and
superficial cervical lymph node or from 1 × 106 PBMCs using QIAamp DNA mini kit
(Qiagen) according to the manufacturer’s protocol.
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The viral RNA was reverse transcribed by using Omniscript RT Kit (Qiagen). Briefly, RT
reaction mixtures consisted of 5 µl of purified viral RNA, 4 U of Omniscript Reverse
transcriptase, 0.5 mM of each dNTP, 1 µmol of reverse primer (Fenv6, seen below), and 10
U of RNase inhibitor (Promega, WI) in a total volume of 20 µl. Reaction mixtures were
incubated at 37°C for 60 min and followed by 95°C for 3 min to inactivate Omniscript
Reverse transcriptase.
PCR
An aliquot containing 0.1 to 1 µg of genomic DNA or 5 µl cDNA was added to a first-round
reaction of 50 µl containing 1× Hotstart PCR buffer, 2.5 U HotStart Taq DNA Polymerase,
200 µM of each dNTP, 0.5 µmol of each first-round primers (Fenv1—forward and Fenv6—
reverse) (Fenv1-5′-946GCTATTGTACAGACCCATT AC-3′;
Fenv6-5′-1605GTACAGTTACAATTCATATACCC-3′). Outer terminal primers (Fenv1
and Fenv6) amplified a 699-bp fragment, covering all of the V3 and V4 regions. A volume
of 2 µl of the product of the first PCR reaction was added to 50 µl of the second PCR mix,
containing 1× Hotstart PCR buffer, 2.5 U HotStart Taq DNA Polymerase, 200 µM of each
dNTP, 0.5 µmol of each internal primer Fenv2 and Fenv3
(Fenv2-5′-971TCCCACTGATCAATTATACATTTGG-3′;
Fenv3-5′-1407GTCATCTACCTTCATAGTAAACCCG-3′). Standard PCR parameters were
95°C for 15 min to activate HotStart Taq DNA Polymerase, 30 cycles of 94°C for 15 s,
58°C for 30 s (or 56°C for 30 s during the second round), and 72°C for 1 min. Each round
was followed by a final extension at 72°C for 7 min. An aliquot of 8 µl nested PCR product
was first analyzed by agarose gel electrophoresis for a single, ethidium bromide–staining
band to check the correct molecular weight and concentrations.
Probe labeling with BamHI and NdeI
FIV NCSU1 V3–V4 probe was a kind gift from Dr. Ronald Swanstrom (University of North
Carolina at Chapel Hill). Briefly, probes were constructed by amplification from NCSU1
FIV molecular clone JSY3 using primers specific to V3–V4 (Yang et al, 1996). PCR
products were cloned into the pT7Blue vector by using the Perfectly Blunt cloning kit
(Novagen, CA). An aliquot of 10 µg of probe DNA was digested with BamHI at 37°C for 1
h. The probe in the BamHI reaction buffer was labeled by filling in the BamHI overhangs
after adding 50 µM dGTP, 50 µCi of [α−35S]dATP (1,250 Ci/mmol; NEN Life Science
Products, MA), and 10 U of Klenow fragment of DNA polymerase I (NEN Life Science
Products) in 73.5 µl for 15 min at room temperature. The DNA polymerase was inactivated
by the addition of 10 mM EDTA. The unincorporated nucleotides were removed by using a
QIAquick PCR purification kit (Qiagen) and eluting in a final volume of 50 µl. The probe
was released from the plasmid by digestion with NdeI (NEN Life Science Products, MA) at
37°C for 1 h, and NdeI was inactivated at 65°C for 20 min.
Heteroduplex tracking assay
FIV envelope V3–V4 sequence heterogeneity was evaluated using the heteroduplex tracking
assay (HTA), an assay based on mobility alteration of DNA heteroduplexes (Delwart et al,
1993; Nelson et al, 1997). Identical size fragment probe and target DNA were used to
generate a heteroduplex. Heteroduplex annealing reaction mixtures consisted of 7 µl of
unpurified PCR product, 1 µl of 10× annealing buffer (1 M NaCl, 100 mM Tris-HCl [pH
7.5], 20 mM EDTA), 1 µl of labeled probe, and 1 µl loading dye in a total volume of 10 µl.
The mixture of PCR amplicons and labeled probe were denatured at 95°C for 2 min
followed by annealing at room temperature for 5 min. The heteroduplexes were separated by
electrophoresis in a 6% naïve polyacrylamide gel (acrylamide-bisacrylamide, 37.5:1) in 1×
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Tris-borate-EDTA buffer by using a model V16-2 vertical gel apparatus run at 17 mA per
gel for 5.5 h. The DNA was allowed to migrate until the fastest migrating DNA
(homoduplex) nearly reached the bottom of the gel. The gels were dried and exposed to x-
ray film. Heteroduplex bands should be located between the single probe and homoduplex
band. All amplifications and HTA analyses were run in duplicate to validate the quality of
sampling. To quantify the relative abundance of each band, a digital scan of the optical
density was made over the same length (same number of pixels) of each lane within a gel
starting at the loading site and ending just below the homoduplex band. The average optical
density across the width of the lane was calculated at each position to give the optical
density profile with a resolution of approximately 0.1 mm. Bands were matched based on
their relative mobility within the gel calculated as the distance from the loading site to the
band as a proportion of the distance from the loading site to the homoduplex band. The
signal intensity of each band in the gel was quantified by measuring the average and
integrated optical density of a standard region encompassing each band (Metamorph
software; Universal Imaging). Optical densities were corrected for background and
normalized to the total integrated optical density of all bands in the lane. The relative
abundance of a given band within a sample was expressed as the percentage of the total
signal for all bands within the sample. When comparing the relative difference in the
expression pattern between two samples (e.g., samples A and B), the percent difference was
calculated as:
where A1 is the relative abundance of the first band for sample A and B1 is the relative
abundance of the first band for sample B. The total number of viral HTA bands is designated
by n. The absolute values of the differences were used to allow for both increases and
decreases in relative abundance. The sum of the total differences was divided by 2 because
an increase in the relative abundance of one band must result in the concomitant decrease in
another. Therefore, the maximum amount of change between two samples of 100% would
indicate no bands in common between two virus populations. Identical HTA patterns would
have a score of 0%.
Specificity of the HTA
Several negative and positive HTA controls were run with the samples including a sample of
the inoculum to give an indication of the HTA pattern for the initial input virus. In addition,
the reproducibility of each HTA pattern was verified by running each HTA in duplicate and
analyzing sequential samples over time. All major peaks defined in the present analysis were
seen in replicate samples, greatly reducing the likelihood that a particular observation was
due to a random amplification of a very minor (insignificant) variant. It is also noteworthy
that high CSF viral loads induced by the intraventricular inoculations provided high copy
numbers of viral RNA for HTA sampling. Lower copy numbers were available for viral
DNA but in each case, bands were generally reproduced in duplicate samples and other
tissues. We cannot rule out the possibility that low copy numbers in some tissues might have
restricted the number of variants that could be resolved. Therefore the absence of bands in
tissues was interpreted cautiously. In general, the FIV HTA did not resolve bands as well as
HIV-1 HTA. This may be due in part to less sequence variation in the FIV env. Optical
density profiles were used to help resolve bands that, in some cases, were not highly
distinctive. With these limitations in mind, we were conservative in the identification of
major variants (V1 to V7). Each was based on the appearance of very clear peaks in the
HTA that were reproduced in multiple samples both within and between animals.
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The statistical significance of the mean percent difference between the paired CSF and
plasma at initial or rebounding CSF viral peak, or the mean percent difference in the viral
variants between brain regions and PBMCs was determined by a paired t test. The viral
diversity in plasma between the i.c.v. cats and i.p. cats was determined by an unpaired t test.
Differences were considered significant if the P value was ≤0.05. All statistical calculations
were done using Graphpad Prism software.
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V3–V4 HTA patterns of the plasma (P) FIV over time in two typical cats. A, The negative
controls of FIV NCSU1 env V3–V4–specific HTA. S35-labeled probes were run with
(heated) or without the denaturing step (unheated), or probes were run with the internal
primers for nested PCR (PCR primers), or with the PCR product of the probe plasmid and
uninfected (FIV Neg) control samples. The single-stranded probe (ss probe) and the fastest
migration homoduplex (ds probe) are indicated by arrows. B, The plasma HTA patterns of
two typical cats. Plasma sampled at the time of the initial CSF peak, the second CSF peak
and the final time point was selected to analyze viral env evolution over time. The inoculum
was also run to show the initial virus mix. The lower portion of gel containing all the
heteroduplexes is shown. The week post inoculation is indicated at the bottom of each lane
(e.g., P4 = plasma at 4 weeks). C, The optical density profile of the V3–V4 HTA pattern at
the initial plasma viremia and the last time point in cat 6 and cat 4. The optical density and
mobility was measured by Metamorph software after scanning the x-ray films. The relative
optical density and mobility was calculated as described in Materials and Methods.
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According to their relative mobility, the major variants were designated V1 to V7. The
number above the dashed line identifies each variant.
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Viral evolution in plasma over time for each cat following i.c.v. or i.p. inoculation. The FIV
env genotypes in plasma were analyzed by HTA. The divergence from the inoculum at each
time point was calculated and plotted at intervals representing the initial viremia (2 to 4
weeks), the time during which the second CSF peak emerged (9 to 24 weeks) and the final
time point at euthanasia. Each point reflects the divergence seen for an individual cat. The
black circles represent the i.c.v. cats (cats 1 to 6) and the open circles represent the i.p. cats
(cats 10 to 12). The horizontal bar and number illustrate the mean value.
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Comparison of V3–V4 env variants in paired CSF (C) and plasma (P) samples at the initial
and second CSF viral peak in cat 6. A, The HTA patterns from CSF (C) and plasma (P)
sampled at 4 and 24 weeks post inoculation. The bottom portion of the gel containing all the
heteroduplexes is shown. A variant unique to the CSF at this time point (V3 marked with the
solid star) and a variant enriched in the CSF (V6 marked with the open star) are seen in
these samples. B, The optical density profiles illustrating the quantification of the HTA
patterns in the gel. The number above the dashed line identifies each variant.
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Comparison of V3–V4 env variants in the paired CSF (C) and plasma (P) samples for the
initial or second CSF viral peak in cat 5. A, The HTA patterns of the CSF (C) and plasma
(P) at 2 and 9 weeks post inoculation are illustrated. A variant is seen in the CSF that is not
apparent in the plasma (V7 marked with the solid star) as well as a variant that is enriched in
the CSF (V5 marked with the open star). B, The optical density profiles illustrating the
quantification of the HTA patterns in the gel. The number above the dashed line identifies
each variant.
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Comparison of V3–V4 env variants in the CSF (top panel) and various brain regions (bottom
panel). The env variants in the CSF FIV RNA for the first and second CSF viral peaks and
the FIV DNA from the brain regions at euthanasia were characterized by V3–V4 HTA. The
optical density profiles from four cats are shown to illustrate the variation in HTA patterns.
The dashed line marks the position of major variants in the CSF. CTX, frontal cortex gray
matter; WM, underlying cortical white matter; IC-Put, internal capsule/putamen.
Liu et al. Page 21














Correlation of the abundance of shared variants between periventricular regions. A,
Correlation of the relative abundance of shared variants between the choroid plexus (ChP)
and CSF. Variants expressed in both the choroid plexus and the CSF were compared based
on their relative abundance. The abundance of these shared variants in the ChP was
significantly correlated with the variants in the initial CSF peak but not the second peak. B,
Correlation of the relative abundance of the shared variants between caudate and the
subcortical white matter (CTX White) or the ChP. A significant correlation in the abundance
of FIV DNA variants was seen between the periventricular tissue regions.
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The average divergence of proviral DNA in the choroid plexus (ChP), cortex, and basal
ganglia from matched PBMCs. Divergence of the HTA patterns of PBMCs was first
calculated relative to the inoculum to provide an indication of the variability in FIV proviral
env sequences across all cats. These sequences were found to be relatively stable with an
average divergence of 15.7% ± 2.4%. The 95% confidence limit was calculated and used as
a reference for normal variation in FIV env DNA sequences (dashed line). The ChP, the
cortex (the frontal cortex gray matter and subcortical white matter CTX-white combined)
and the basal ganglia (caudate nucleus and internal capsule/putamen combined) in each cat
were compared with the time matched PBMCs. The mean diversity from the matched
PBMC HTA profile (± SEM) is shown. P values reflect the comparison (t test) of each
region to matched PBMCs.
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Analysis of V3–V4 variants in the CNS, blood and lymph node at euthanasia by V3–V4–
specific HTA in cat 5. Considerable variation in FIV V3–V4 env HTA is seen between
different brain regions while systemic tissues (LN, PBMCs, and plasma) are more
homogeneous. This type of variation was typical across all cats although each showed a
unique pattern. CTX-gray, frontal cortex gray matter; CTX-white, subcortical white matter;
IC-Put, internal capsule/putamen; ChP, choroid plexus; LN, superficial cervical lymph node.
Arrows show the position of specific variants.
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